Intellectual Property Magazine

PTAB declines Gilead’s IPR request over HIV patents

Gilead Sciences has failed in its attempt to invalidate USgovernment owned patents related to HIV prevention, which it is accused ofinfringing.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, click Log In button.